The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE
George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’
George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’View Video
Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin America
Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin AmericaView Video

Latest Share Chat

Issue of Equity

7 Mar 2019 17:50

RNS Number : 2366S
Maven Income and Growth VCT 5 PLC
07 March 2019
 

Maven Income and Growth VCT 5 PLC (the Company)

 

Issue of Equity

 

On 26 September 2018, the Company launched an offer for subscription for new ordinary shares of 10p each (Ordinary Shares) to raise up to £15 million, with an over-allotment facility for up to a further £5 million (the Offer). On 20 February 2019 the Company announced that the Board of the Company had resolved to exercise its discretion to utilise the over-allotment facility of £5 million.

 

Pursuant to the Offer, and the £5,644,901 of valid applications received from 19 December 2018 until noon on 4 March 2019 in respect of the 2018/2019 tax year, the Company has issued and allotted 14,755,373 new Ordinary Shares on 6 March 2019. In accordance with the allotment formula set out in the prospectus for the Offer, the offer prices at which the shares were issued were in the range of 36.94p to 37.93p per Ordinary Share and, as a result, the number of Ordinary Shares now in issue is 113,265,297. Therefore, the total number of voting rights in the Company is 113,265,297.

 

In respect of this allotment, an application will be made by the Company to the UK Listing Authority and to the London Stock Exchange for the new Ordinary Shares so issued to be admitted to the Official List and to trading on the London Stock Exchange's main market for listed securities. It is expected that the admission of the new Ordinary Shares will become effective and dealings will commence on or around 11 March 2019.

 

The above statement of Voting Capital may be used by Shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest, or a change to their interest, in the Company under the FCA's Disclosure Guidance and Transparency Rules.

 

The Board of the Company intends that a further allotment in respect of applications for the 2018/2019 tax year will take place on or before 5 April 2019 and that a final allotment, in respect of applications for the 2019/2020 tax year, will take place on or before 26 April 2019

 

For further information, please contact:

 

Maven Capital Partners UK LLP

Telephone: 0141 306 7400

E-mail: enquiries@mavencp.com

 

Maven Capital Partners UK LLP

Company Secretary

 

7 March 2019

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
IOECKODQOBKDNNK

Related Shares

Back to RNS

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.